Skip to content

Safety and feasibility of newly developed twist biliary stent in hilar cholangiocarcinoma : A pilot study

Safety and feasibility of newly developed twist biliary stent in hilar cholangiocarcinoma : A pilot study

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CRIS
Registry ID
KCT0009258
Enrollment
32
Registered
2024-03-21
Start date
2024-01-23
Completion date
Unknown
Last updated
2026-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Subjects who meet all selection and exclusion criteria are hospitalized before the procedure date according to the standard treatment procedure of the clinical trial institution, and

Sponsors

Hallym University Medical Center-Dongtan
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? Adult male over 19 years of age, patients diagnosed with hepaticobiliary cancer (Hilar cholangiocarcinoma) by CT, MRI, EUS, or other imaging tests requiring endoscopic retrograde cholangiocarcinoma (ERCP) ? Where participating in a clinical trial, complying with treatment and puncture, and willing to visit a hospital for all follow-up evaluations In the case of voluntarily signing a written consent form after hearing an explanation of the purpose, method and effectiveness of this clinical trial

Exclusion criteria

Exclusion criteria: ? In cases of hemorrhagic disease or coagulation disorder (e.g. DIC) or platelet levels below 60,000/mm3 or INR greater than 1.5 ? If anticoagulant therapy cannot be postponed ? When hemodynamically unstable (e.g. shock) ? A woman of childbearing age who is unable to use proper contraception or is pregnant ? In the case of a psychiatric condition or condition in which participation in clinical trials is not possible (e.g. dementia, seizure) ? If the other tester determines that the twist bile stent procedure is impossible

Design outcomes

Primary

MeasureTime frame
Opening period of stent

Secondary

MeasureTime frame
Opening rate of stent;overall survival

Countries

Korea, Republic of

Contacts

Public ContactSe Woo Park

Hallym University Medical Center-Dongtan

britnepak@outlook.com+82-31-8086-2858

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Apr 23, 2026